✦ LIBER ✦

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily

✍ Scribed by Christophe Hézode; Stéphane Chevaliez; Magali Bouvier-Alias; Françoise Roudot-Thoraval; Rozenn Brillet; Elie-Serge Zafrani; Daniel Dhumeaux; Jean-Michel Pawlotsky

Book ID: 116651301
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 125 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2007.01.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of adefovir 20 mg to improve sub

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine

✍ M. Viganò; P. Lampertico; F. Facchetti; G. Lunghi; M. Colombo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Efficacy and safety of adefovir dipivoxil 20&#xa0;mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10&#xa0;mg daily

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily